These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 37442895)

  • 1. The potential roles of lncRNA TINCR in triple negative breast cancer.
    Azman AA; Siok-Fong C; Rajab NF; Md Zin RR; Ahmad Daud NN; Mohamad Hanif EA
    Mol Biol Rep; 2023 Sep; 50(9):7909-7917. PubMed ID: 37442895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum lncRNA TINCR Serve as a Novel Biomarker for Predicting the Prognosis in Triple-Negative Breast Cancer.
    Wang X; Li S; Xiao H; Deng X
    Technol Cancer Res Treat; 2020; 19():1533033820965574. PubMed ID: 33084530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of EMT-related lncRNA in the process of triple-negative breast cancer metastasis.
    Zhang H; Wang J; Yin Y; Meng Q; Lyu Y
    Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33443534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of novel three-long noncoding RNA signatures as a diagnostic and prognostic biomarkers of human triple-negative breast cancer.
    Fan CN; Ma L; Liu N
    J Cell Biochem; 2019 Mar; 120(3):3185-3196. PubMed ID: 30203490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imbalance of Molecular Module of TINCR-miR-761 Promotes the Metastatic Potential of Early Triple Negative Breast Cancer and Partially Offsets the Anti-Tumor Activity of Luteolin.
    Zhang ML; Liu WW; Li WD
    Cancer Manag Res; 2021; 13():1877-1886. PubMed ID: 33654432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
    Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O
    Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of serum exosomal SUMO1P3 predicts unfavorable prognosis in triple negative breast cancer.
    Na-Er A; Xu YY; Liu YH; Gan YJ
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):154-160. PubMed ID: 33506903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness.
    Shin VY; Chen J; Cheuk IW; Siu MT; Ho CW; Wang X; Jin H; Kwong A
    Cell Death Dis; 2019 Mar; 10(4):270. PubMed ID: 30894512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of miRNA and lncRNA in triple-negative breast cancer.
    Xu J; Wu KJ; Jia QJ; Ding XF
    J Zhejiang Univ Sci B; 2020 Sept.; 21(9):673-689. PubMed ID: 32893525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA DANCR upregulation induced by TUFT1 promotes malignant progression in triple negative breast cancer via miR-874-3p-SOX2 axis.
    Wu G; Zhou H; Li D; Zhi Y; Liu Y; Li J; Wang F
    Exp Cell Res; 2020 Nov; 396(2):112331. PubMed ID: 33058834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA ZFAS1 inhibits triple-negative breast cancer by targeting STAT3.
    Sharma U; Barwal TS; Khandelwal A; Malhotra A; Rana MK; Singh Rana AP; Imyanitov EN; Vasquez KM; Jain A
    Biochimie; 2021 Mar; 182():99-107. PubMed ID: 33429003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNAs in triple-negative breast cancer: A new frontier in the regulation of tumorigenesis.
    Thakur KK; Kumar A; Banik K; Verma E; Khatoon E; Harsha C; Sethi G; Gupta SC; Kunnumakkara AB
    J Cell Physiol; 2021 Dec; 236(12):7938-7965. PubMed ID: 34105151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA LUCAT1 facilitates tumorigenesis and metastasis of triple-negative breast cancer through modulating miR-5702.
    Mou E; Wang H
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31399501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lncRNA prostate cancer-associated transcript 18 upregulates activating transcription factor 7 to prevent metastasis of triple-negative breast cancer via sponging miR-103a-3p.
    Zhang J; Liu D; Deng G; Wang Q; Li L; Zhang J; Wu H
    Bioengineered; 2021 Dec; 12(2):12070-12086. PubMed ID: 34787047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Classification of Breast Cancer Utilizing Long Non-Coding RNA (lncRNA) Transcriptomes Identifies Novel Diagnostic lncRNA Panel for Triple-Negative Breast Cancer.
    Shaath H; Elango R; Alajez NM
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noncoding RNAs in triple negative breast cancer: Mechanisms for chemoresistance.
    Xia M; Zu X; Chen Z; Wen G; Zhong J
    Cancer Lett; 2021 Dec; 523():100-110. PubMed ID: 34601022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA T376626 is a promising serum biomarker and promotes proliferation, migration, and invasion via binding to LAMC2 in triple-negative breast cancer.
    He Y; Xiao B; Lei T; Xuan J; Zhu Y; Kuang Z; Liu J; He J; Li L; Sun Z
    Gene; 2023 Apr; 860():147227. PubMed ID: 36709879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer.
    Jadaliha M; Zong X; Malakar P; Ray T; Singh DK; Freier SM; Jensen T; Prasanth SG; Karni R; Ray PS; Prasanth KV
    Oncotarget; 2016 Jun; 7(26):40418-40436. PubMed ID: 27250026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Noncoding RNA Highly Up-regulated in Liver Cancer Predicts Unfavorable Outcome and Regulates Metastasis by MMPs in Triple-negative Breast Cancer.
    Shi F; Xiao F; Ding P; Qin H; Huang R
    Arch Med Res; 2016 Aug; 47(6):446-453. PubMed ID: 27986124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA ANRIL promotes carcinogenesis via sponging miR-199a in triple-negative breast cancer.
    Xu ST; Xu JH; Zheng ZR; Zhao QQ; Zeng XS; Cheng SX; Liang YH; Hu QF
    Biomed Pharmacother; 2017 Dec; 96():14-21. PubMed ID: 28961506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.